Analyst stock forecast
TransMedics Group Stock Forecast and Analyst Price Target
TMDX analyst target range, upside, consensus rating and coverage count.
Direct answer
TransMedics Group's average price target is $98.80.
The target implies +23.1% from the recorded current price, and the consensus rating is Buy.
The verified range is $73.00 to $125.00, with 10 analysts in the current consensus when available.
Forecast evidence checked August 7, 2026.
Verified data
- Current price
- $80.25
- Average price target
- $98.80
- High price target
- $125.00
- Low price target
- $73.00
- Target upside
- +23.1%
- Consensus rating
- Buy
- Analysts
- 10
- Evidence date
- August 7, 2026
- Valid through
- August 14, 2026